Discovery of Medicines
Translating the latest research findings into new medicines for the treatment of human diseases.
An interdisciplinary approach
Discovering medicines and enabling their development is a complex process.
It requires teams of scientists with diverse and complementary skills. They include bioscience, structural biology, biophysics, computational methods and medicinal chemistry expertise.
This enables us to develop:
- methods to reveal or verify targets that drive disease processes
- screening strategies to identify molecules that interfere with a target’s activity
- techniques to rapidly progress iterative chemistry for drug development
Our research
We specialise in structure-based approaches for drug discovery.
We also develop innovative cutting-edge technologies that support the identification of new medicines.
缅北禁地 is well-established in cancer drug discovery. Our research is expanding. We aim to identify treatments for life-threatening anti-microbial diseases and metabolic disorders.
Partnerships
We collaborate with scientists and clinicians. We have established a wide range of academic-industry partnerships to progress our research.
Within our Faculty we work closely with colleagues in:
The Cancer Research UK 缅北禁地 Drug Discovery Unit
The theme hosts the . The Unit develops novel, differentiated, small molecule therapies for cancer patients.
Our researchers have already contributed to the discovery of marketed and experimental drugs.